Qurient Co., Ltd. (KOSDAQ:115180)
South Korea · Delayed Price · Currency is KRW 32,250
-1,450 (-4.30%)
At close: Feb 27, 2026
Qurient Revenue
Qurient had revenue of 1.69B KRW in the quarter ending September 30, 2025, a decrease of -25.32%. This brings the company's revenue in the last twelve months to 8.28B, down -5.45% year-over-year. In the year 2024, Qurient had annual revenue of 9.18B with 1.64% growth.
Revenue (ttm)
8.28B
Revenue Growth
-5.45%
P/S Ratio
157.48
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.30T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.18B | 148.03M | 1.64% |
| Dec 31, 2023 | 9.03B | 563.25M | 6.65% |
| Dec 31, 2022 | 8.47B | 3.58B | 73.33% |
| Dec 31, 2021 | 4.89B | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HansBiomed | 100.17B |
| Aimed Bio | 29.65B |
| ROKIT Healthcare | 20.33B |
| S.Biomedics | 16.96B |
| JS Link | 16.14B |
| AprilBio | 8.97B |
| Y-Biologics | 3.61B |
| IntoCell | 1.68B |